Bezlotoxumab
Bezlotoxumab has been studied in 1 paper since 2024: 1 observational study in people. The newest paper, Aug 6, 2024: “Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?”.
1 paper studies itUpdated
- Humans1
Latest
Age and Ageing
Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?
Cohort study of 476 peoplePopulations